Cargando…
5xFAD mice do not have myenteric amyloidosis, dysregulation of neuromuscular transmission or gastrointestinal dysmotility
BACKGROUND: Alterations in gastrointestinal (GI) function and the gut‐brain axis are associated with progression and pathology of Alzheimer's Disease (AD). Studies in AD animal models show that changes in the gut microbiome and inflammatory markers can contribute to AD development in the centra...
Autores principales: | Yelleswarapu, Narayana Krishna, Masino, Marlene, Henderson, Skye, Fernandes, Roxanne, Swain, Greg, Galligan, James J., Xu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718934/ https://www.ncbi.nlm.nih.gov/pubmed/36458522 http://dx.doi.org/10.1111/nmo.14439 |
Ejemplares similares
-
Impact of Myenteric Plexus Alterations on Diabetes Related Gastrointestinal Dysmotility
por: Park, Kyung Sik
Publicado: (2013) -
Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice
por: Prange-Kiel, Janine, et al.
Publicado: (2016) -
Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease
por: Wang, Lu, et al.
Publicado: (2016) -
Axonal and myelinic pathology in 5xFAD Alzheimer’s mouse spinal cord
por: Chu, Tak-Ho, et al.
Publicado: (2017) -
The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2020)